为二甲中毒造成的双向腹腔动心:一个病例报告
Luís Henrique Sardinha Borborema1, Daniel A Adedd Filho2
1Internal Medicine, Hospital das Clínicas da Faculdade de Medicina da USP, São Paulo, BRA.
Cureus
|January 9, 2026
概括
意外的二甲摄入引发了双向心室动脉冲动 (BVT) 和心脏骤停在一个年轻的女人. 这一案例突出了这种罕见心律失常的新奇原因,强调了溶剂毒性风险.
科学领域:
- 心脏病学 心脏病学
- 毒理学 毒理学 毒理学
- 紧急医疗 紧急医疗
背景情况:
- 双向腹腔动脉动脉 (BVT) 是一种罕见的腹腔动脉动脉,已知原因有限.
- 滥用挥发性吸入剂,特别是使用有机溶剂,对健康构成重大风险.
研究的目的:
- 报告一种双向腹腔动脉冲动 (BVT) 和心脏骤停的新病例.
- 确定意外摄入二甲 (一种有机溶剂) 作为BVT的潜在触发因素.
主要方法:
- 一个以前健康的30岁妇女的病例报告.
- 临床评估包括对结构性心脏病,电解质失衡和药物暴露的评估.
- 毒理学分析以确定心律失常的原因.
主要成果:
- 患者在意外摄入二甲后出现了BVT和随后的心脏骤停.
- 没有发现潜在的结构性心脏病,电解质干扰或相关药物暴露.
- 滴甲中毒被确定为BVT的可能原因.
结论:
- 意外摄入二甲可能会导致双向腹腔动脉短心和心脏骤停.
- 这种病例代表了BVT以前未报告的病因.
- 意识到溶剂毒性对于管理无法解释的心室节律失常至关重要.
相关概念视频
Dysrhythmias II: Classification of Tachyarrhythmias
484
Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
484
Cardiomyopathy II: Dilated Cardiomyopathy
457
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
457
Depolarizing Blockers: Pharmocokinetics
560
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
560
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
453
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
453
Acute Respiratory Failure-III
761
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
761
Anticholinesterase Agents: Poisoning and Treatment
1.5K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.5K


